Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T02:07:46.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:04:15.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:47:28.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T02:27:53.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study details with an error screen; as a result, the trial record is inaccessible to users.
    Difference
    23%
    Check dated 2026-09-20T01:01:36.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The revision label on the study page was updated from v3.6.5 to v3.6.6, indicating a small metadata update to the record. This change does not modify the study content or data.
    Difference
    0.0%
    Check dated 2026-08-29T20:04:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.